Authors:
Marie E. Alutis Charité — University Medicine Berlin, Berlin, Germany

Search for other papers by Marie E. Alutis in
Current site
Google Scholar
PubMed
Close
,
Ursula Grundmann Charité — University Medicine Berlin, Berlin, Germany

Search for other papers by Ursula Grundmann in
Current site
Google Scholar
PubMed
Close
,
André Fischer Charité — University Medicine Berlin, Berlin, Germany

Search for other papers by André Fischer in
Current site
Google Scholar
PubMed
Close
,
Ulrike Hagen Charité — University Medicine Berlin, Berlin, Germany

Search for other papers by Ulrike Hagen in
Current site
Google Scholar
PubMed
Close
,
Anja A. Kühl Charité — University Medicine Berlin, Berlin, Germany

Search for other papers by Anja A. Kühl in
Current site
Google Scholar
PubMed
Close
,
Ulf B. Göbel Charité — University Medicine Berlin, Berlin, Germany

Search for other papers by Ulf B. Göbel in
Current site
Google Scholar
PubMed
Close
,
Stefan Bereswill Charité — University Medicine Berlin, Berlin, Germany

Search for other papers by Stefan Bereswill in
Current site
Google Scholar
PubMed
Close
, and
Markus M. Heimesaat Charité — University Medicine Berlin, Berlin, Germany

Search for other papers by Markus M. Heimesaat in
Current site
Google Scholar
PubMed
Close
Open access

Matrix metalloproteinases (MMP)-2 and -9 (also referred to gelatinases-A and -B, respectively) are upregulated in the inflamed gut of mice and men. We recently demonstrated that synthetic gelatinase blockage reduced large intestinal pro-inflammatory immune responses and apoptosis following murine Campylobacter (C.) jejuni infection. In order to address which gelatinase mediates C. jejuni-induced immune responses, gnotobiotic MMP-2−/−, MMP-9−/−, and wildtype (WT) mice were generated by broadspectrum antibiotic treatment and perorally infected with C. jejuni strain 81-176. The pathogen stably colonized the murine intestinal tract irrespective of the genotype but did not translocate to extra-intestinal compartments. At days 8 and 14 postinfection (p.i.), less pronounced colonic histopathological changes were observed in infected MMP-2−/− mice, less distinct epithelial apoptosis, but more epithelial proliferation in both MMP-2−/− and MMP-9−/− mice, as compared to WT controls. Reduced immune responses in gelatinase- deficient mice were characterized by lower numbers of effector as well as innate and adaptive immune cells within the colonic mucosa and lamina propria. The expression of IL-22, IL-18, IL-17A, and IL-1β mRNA was higher in the colon of MMP-2−/− as compared to WT mice. In conclusion, both MMP-2 and MMP-9 are differentially involved in mediating C. jejuni-induced intestinal immunopathology.

  • 1.

    Young KT , Davis LM, Dirita VJ: Campylobacter jejuni: molecular biology and pathogenesis. Nat Rev Microbiol 5, 665679 (2007)

  • 2.

    Dasti JI , Tareen AM, Lugert R, Zautner AE, Gross U: Campylobacter jejuni: a brief overview on pathogenicityassociated factors and disease-mediating mechanisms. Int J Med Microbiol 300, 205211 (2010)

    • Search Google Scholar
    • Export Citation
  • 3.

    Lane JA , Mehra RK, Carrington SD, Hickey RM: The food glycome: a source of protection against pathogen colonization in the gastrointestinal tract. Int J Food Microbiol 142, 113 (2010)

    • Search Google Scholar
    • Export Citation
  • 4.

    Guerry P , Szymanski CM: Campylobacter sugars sticking out. Trends Microbiol 16, 428435 (2008)

  • 5.

    Alter T , Bereswill S, Glunder G, Haag LM, Hanel I, et al.: [Campylobacteriosis of man: livestock as reservoir for Campylobacter species]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 54, 728734 (2011)

    • Search Google Scholar
    • Export Citation
  • 6.

    Kist M , Bereswill S: Campylobacter jejuni. Contrib Microbiol 8, 150165 (2001)

  • 7.

    Wakerley BR , Uncini A, Yuki N, Group GBSC, Group GBSC: Guillain-Barre and Miller Fisher syndromes –new diagnostic classification. Nat Rev Neurol 10, 537544 (2014)

    • Search Google Scholar
    • Export Citation
  • 8.

    van Spreeuwel JP , Duursma GC, Meijer CJ, Bax R, Rosekrans PC, et al.: Campylobacter colitis: histological immunohistochemical and ultrastructural findings. Gut 26, 945951 (1985)

    • Search Google Scholar
    • Export Citation
  • 9.

    Walker RI , Caldwell MB, Lee EC, Guerry P, Trust TJ, et al.: Pathophysiology of Campylobacter enteritis. Microbiol Rev 50, 8194 (1986)

  • 10.

    Masanta WO , Heimesaat MM, Bereswill S, Tareen AM, Lugert R, et al.: Modification of intestinal microbiota and its consequences for innate immune response in the pathogenesis of campylobacteriosis. Clin Dev Immunol 2013, 526860 (2013)

    • Search Google Scholar
    • Export Citation
  • 11.

    Bereswill S , Fischer A, Plickert R, Haag LM, Otto B, et al.: Novel murine infection models provide deep insights into the “menage a trois” of Campylobacter jejuni, microbiota and host innate immunity. PLoS One 6, e20953 (2011)

    • Search Google Scholar
    • Export Citation
  • 12.

    Birkedal-Hansen H , Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, et al.: Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 4, 197250 (1993)

    • Search Google Scholar
    • Export Citation
  • 13.

    Goetzl EJ , Banda MJ, Leppert D: Matrix metalloproteinases in immunity. J Immunol 156, 14 (1996)

  • 14.

    Brinckerhoff CE , Matrisian LM: Matrix metalloproteinases: a tail of a frog that became a prince. Nat Rev Mol Cell Biol 3, 207214 (2002)

    • Search Google Scholar
    • Export Citation
  • 15.

    Nelson AR , Fingleton B, Rothenberg ML, Matrisian LM: Matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol 18, 11351149 (2000)

    • Search Google Scholar
    • Export Citation
  • 16.

    Crawford HC , Matrisian LM: Mechanisms controlling the transcription of matrix metalloproteinase genes in normal and neoplastic cells. Enzyme Protein 49, 2037 (1996)

    • Search Google Scholar
    • Export Citation
  • 17.

    Saren P , Welgus HG, Kovanen PT: TNF-alpha and IL-1beta selectively induce expression of 92-kDa gelatinase by human macrophages. J Immunol 157, 41594165 (1996)

    • Search Google Scholar
    • Export Citation
  • 18.

    Salmela MT , MacDonald TT, Black D, Irvine B, Zhuma T, et al.: Upregulation of matrix metalloproteinases in a model of T cell mediated tissue injury in the gut: analysis by gene array and in situ hybridisation. Gut 51, 540547 (2002)

    • Search Google Scholar
    • Export Citation
  • 19.

    Munoz M , Heimesaat MM, Danker K, Struck D, Lohmann U, et al.: Interleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17. J Exp Med 206, 30473059 (2009)

    • Search Google Scholar
    • Export Citation
  • 20.

    Heimesaat MM , Dunay IR, Fuchs D, Trautmann D, Fischer A, et al.: The distinct roles of MMP-2 and MMP-9 in acute DSS colitis. Eur J Microbiol Immunol (Bp) 1, 302310 (2011)

    • Search Google Scholar
    • Export Citation
  • 21.

    Bailey CJ , Hembry RM, Alexander A, Irving MH, Grant ME, et al.: Distribution of the matrix metalloproteinases stromelysin, gelatinases A and B, and collagenase in Crohn’s disease and normal intestine. J Clin Pathol 47, 113116 (1994)

    • Search Google Scholar
    • Export Citation
  • 22.

    Baugh MD , Perry MJ, Hollander AP, Davies DR, Cross SS, et al.: Matrix metalloproteinase levels are elevated in inflammatory bowel disease. Gastroenterology 117, 814822 (1999)

    • Search Google Scholar
    • Export Citation
  • 23.

    von Lampe B , Barthel B, Coupland SE, Riecken EO, Rosewicz S: Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease. Gut 47, 6373 (2000)

    • Search Google Scholar
    • Export Citation
  • 24.

    Vanlaere I , Libert C: Matrix metalloproteinases as drug targets in infections caused by gram-negative bacteria and in septic shock. Clin Microbiol Rev 22, 224239 (2009), Table of Contents

    • Search Google Scholar
    • Export Citation
  • 25.

    Handley SA , Miller VL: General and specific host responses to bacterial infection in Peyer’s patches: a role for stromelysin-1 (matrix metalloproteinase-3) during Salmonella enterica infection. Mol Microbiol 64, 94110 (2007)

    • Search Google Scholar
    • Export Citation
  • 26.

    Kundu P , Mukhopadhyay AK, Patra R, Banerjee A, Berg DE, et al.: Cag pathogenicity island-independent up-regulation of matrix metalloproteinases-9 and -2 secretion and expression in mice by Helicobacter pylori infection. J Biol Chem 281, 3465134662 (2006)

    • Search Google Scholar
    • Export Citation
  • 27.

    Bergin PJ , Raghavan S, Svensson H, Starckx S, Van Aelst I, et al.: Gastric gelatinase B/matrix metalloproteinase-9 is rapidly increased in Helicobacter felis-induced gastritis. FEMS Immunol Med Microbiol 52, 8898 (2008)

    • Search Google Scholar
    • Export Citation
  • 28.

    Takeda M , Imada K, Sato T, Ito A: Activation of human progelatinase A/promatrix metalloproteinase 2 by Escherichia coli-derived serine proteinase. Biochem Biophys Res Commun 268, 128132 (2000)

    • Search Google Scholar
    • Export Citation
  • 29.

    Alutis ME , Grundmann U, Fischer A, Kuhl AA, Bereswill S, et al.: Selective gelatinase inhibition reduces apoptosis and pro-inflammatory immune cell responses in Campylobacter jejuni-infected gnotobiotic IL-10 deficient mice. Eur J Microbiol Immunol (Bp) 4, 213222 (2014)

    • Search Google Scholar
    • Export Citation
  • 30.

    Heimesaat MM , Bereswill S, Fischer A, Fuchs D, Struck D, et al.: Gram-negative bacteria aggravate murine small in testinal Th1-type immunopathology following oral infection with Toxoplasma gondii. J Immunol 177, 87858795 (2006)

    • Search Google Scholar
    • Export Citation
  • 31.

    Haag LM , Fischer A, Otto B, Plickert R, Kuhl AA, et al.: Campylobacter jejuni induces acute enterocolitis in gnotobiotic IL-10–/–mice via Toll-like-receptor-2 and -4 signaling. PLoS One 7, e40761 (2012)

    • Search Google Scholar
    • Export Citation
  • 32.

    Heimesaat MM , Lugert R, Fischer A, Alutis M, Kuhl AA, et al.: Impact of Campylobacter jejuni cj0268c knockout mutation on intestinal colonization, translocation, and induction of immunopathology in gnotobiotic IL-10 deficient mice. PLoS One 9, e90148 (2014)

    • Search Google Scholar
    • Export Citation
  • 33.

    Heimesaat MM , Alutis M, Grundmann U, Fischer A, Tegtmeyer N, et al.: The role of serine protease HtrA in acute ulcerative enterocolitis and extra-intestinal immune responses during Campylobacter jejuni infection of gnotobiotic IL-10 deficient mice. Front Cell Infect Microbiol 4. 77 (2014)

    • Search Google Scholar
    • Export Citation
  • 34.

    Paclik D , Danese S, Berndt U, Wiedenmann B, Dignass A, et al.: Galectin-4 controls intestinal inflammation by selective regulation of peripheral and mucosal T cell apoptosis and cell cycle. PLoS One 3, e2629 (2008)

    • Search Google Scholar
    • Export Citation
  • 35.

    Heimesaat MM , Nogai A, Bereswill S, Plickert R, Fischer A, et al.: MyD88/TLR9 mediated immunopathology and gut microbiota dynamics in a novel murine model of intestinal graft-versus-host disease. Gut 59, 10791087 (2010)

    • Search Google Scholar
    • Export Citation
  • 36.

    Bereswill S , Munoz M, Fischer A, Plickert R, Haag LM, et al.: Anti-inflammatory effects of resveratrol, curcumin and simvastatin in acute small intestinal inflammation. PLoS One 5, e15099 (2010)

    • Search Google Scholar
    • Export Citation
  • 37.

    Heimesaat MM , Fischer A, Alutis M, Grundmann U, Boehm M, et al.: The impact of serine protease HtrA in apoptosis, intestinal immune responses and extra-intestinal histopathology during Campylobacter jejuni infection of infant mice. Gut Pathog 6, 16 (2014)

    • Search Google Scholar
    • Export Citation
  • 38.

    Haag LM , Fischer A, Otto B, Grundmann U, Kuhl AA, et al.: Campylobacter jejuni infection of infant mice: acute enterocolitis is followed by asymptomatic intestinal and extra-intestinal immune responses. Eur J Microbiol Immunol (Bp) 2, 211 (2012)

    • Search Google Scholar
    • Export Citation
  • 39.

    Scholzen T , Gerdes J: The Ki-67 protein: from the known and the unknown. J Cell Physiol 182, 311322 (2000)

  • 40.

    Heimesaat MM , Dunay IR, Fuchs D, Trautmann D, Fischer A, et al.: Selective gelatinase blockage ameliorates acute DSS colitis. Eur J Microbiol Immunol (Bp) 1, 228236 (2011)

    • Search Google Scholar
    • Export Citation
  • 41.

    Haag LM , Fischer A, Otto B, Plickert R, Kuhl AA, et al.: Intestinal microbiota shifts towards elevated commensal Escherichia coli loads abrogate colonization resistance against Campylobacter jejuni in mice. PLoS One 7, e35988 (2012)

    • Search Google Scholar
    • Export Citation
  • 42.

    Heimesaat MM , Bereswill S: Murine infection models for the investigation of Campylobacter jejuni–host interactions and pathogenicity. Berl Munch Tierarztl Wochenschr 128, 98103 (2015)

    • Search Google Scholar
    • Export Citation
  • 43.

    Alutis ME , Grundmann U, Hagen U, Fischer A, Kuhl AA, Gobel UB, et al.: Matrix metalloproteinase-2 mediates intestinal immunopathogenesis in Campylobacter jejuni-infected infant mice. Eur J Microbiol Immunol (Bp) (2015), doi: 10.1556/1886.2015.00025.

    • Search Google Scholar
    • Export Citation
  • 44.

    Eidenschenk C , Rutz S, Liesenfeld O, Ouyang W: Role of IL-22 in microbial host defense. Curr Top Microbiol Immunol 380, 213236 (2014)

  • 45.

    Ouyang WJ , Rutz S, Crellin NK, Valdez PA, Hymowitz SG: Regulation and Functions of the IL-10 Family of Cytokines in Inflammation and Disease. Annual Review of Immunology, Vol 29 29, 71109 (2011)

    • Search Google Scholar
    • Export Citation
  • 46.

    Munoz M , Liesenfeld O, Heimesaat MM: Immunology of Toxoplasma gondii. Immunol Rev 240, 269285 (2011)

  • 47.

    Malik A , Sharma D, St Charles J, Dybas LA, Mansfield LS: Contrasting immune responses mediate Campylobacter jejuni-induced colitis and autoimmunity. Mucosal Immunol 7, 802817 (2014)

    • Search Google Scholar
    • Export Citation
  • 48.

    Edwards LA , Nistala K, Mills DC, Stephenson HN, Zilbauer M, et al.: Delineation of the innate and adaptive T-cell immune outcome in the human host in response to Campylobacter jejuni infection. PLoS One 5, e15398 (2010)

    • Search Google Scholar
    • Export Citation
  • 49.

    Munoz M , Eidenschenk C, Ota N, Wong K, Lohmann U, et al.: Interleukin-22 induces interleukin-18 expression from epithelial cells during intestinal infection. Immunity 42, 321331 (2015)

    • Search Google Scholar
    • Export Citation
  • Collapse
  • Expand

Senior editors

Editor(s)-in-Chief: Dunay, Ildiko Rita, Prof. Dr. Pharm, Dr. rer. nat., University of Magdeburg, Germany

Editor(s)-in-Chief: Heimesaat, Markus M., Prof. Dr. med., Charité - University Medicine Berlin, Germany

Editorial Board

  • Berit Bangoura, Dr. DVM. PhD,  University of Wyoming, USA
  • Stefan Bereswill, Prof. Dr. rer. nat., Charité - University Medicine Berlin, Germany
  • Dunja Bruder, Prof. Dr. rer. nat., University of Magdeburg, Germany
  • Jan Buer, Prof. Dr. med., University of Duisburg, Germany
  • Edit Buzas, Prof. Dr. med., Semmelweis University, Hungary
  • Renato Damatta, Prof. PhD, UENF, Brazil
  • Maria Deli, MD, PhD, DSc, Biological Research Center, HAS, Hungary
  • Olgica Djurković-Djaković, Prof. Phd, University of Belgrade, Serbia
  • Jean-Dennis Docquier, Prof. Dr. med., University of Siena, Italy
  • Zsuzsanna Fabry, Prof. Phd, University of Washington, USA
  • Ralf Ignatius, Prof. Dr. med., Charité - University Medicine Berlin, Germany
  • Achim Kaasch, Prof. Dr. med., Otto von Guericke University Magdeburg, Germany
  • Oliver Liesenfeld, Prof. Dr. med., Inflammatix, USA
  • Matyas Sandor, Prof. PhD, University of Wisconsin, USA
  • Ulrich Steinhoff, Prof. PhD, University of Marburg, Germany
  • Michal Toborek, Prof. PhD, University of Miami, USA
  • Susanne A. Wolf, PhD, MDC-Berlin, Germany

 

Dr. Dunay, Ildiko Rita
Magdeburg, Germany
E-mail: ildiko.dunay@med.ovgu.de

Indexing and Abstracting Services:

  • PubMed Central
  • Scopus
  • ESCI
  • CABI
  • CABELLS Journalytics

 

2024  
Web of Science  
Journal Impact Factor 2.6
Rank by Impact Factor Q3 (Microbiology)
Journal Citation Indicator 0.55
Rank by Journal Citation Indicator Q3 (Microbiology)
Scopus  
CiteScore 4.1
CiteScore rank Q2 (Microbiology - Medical)
SNIP 0.903
Scimago  
SJR index 0.569
SJR Q rank Q3

 

2023  
Web of Science  
Total Cites
WoS
674
Journal Impact Factor 3.3
Rank by Impact Factor

Q2

Impact Factor
without
Journal Self Cites
3.1
5 Year
Impact Factor
3.2
Scimago  
Scimago
H-index
15
Scimago
Journal Rank
0.601
Scimago Quartile Score Microbiology (medical) (Q2)
Microbiology (Q3)
Immunology and Allergy (Q3)
Immunology (Q3)
Scopus  
Scopus
Cite Score
5.0
Scopus
CIte Score Rank
Microbiology (medical) Q2
Scopus
SNIP
0.832

European Journal of Microbiology and Immunology
Publication Model Gold Open Access
Online only
Submission Fee none
Article Processing Charge 900 EUR/article
Regional discounts on country of the funding agency World Bank Lower-middle-income economies: 50%
World Bank Low-income economies: 100%
Further Discounts Editorial Board / Advisory Board members: 50%
Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100%
Subscription Information Gold Open Access
Purchase per Title  

European Journal of Microbiology and Immunology
Language English
Size A4
Year of
Foundation
2011
Volumes
per Year
1
Issues
per Year
4
Founder Akadémiai Kiadó
Founder's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 2062-509X (Print)
ISSN 2062-8633 (Online)